Literature DB >> 736117

Modeling of plasma disappearance of unlabeled insulin in man.

K G Tranberg, H Dencker.   

Abstract

Fifty-two portal and 68 peripheral, brief infusions of unlabeled insulin were given to ambulant, nondiabetic patients. After intraportal insulin infusion (5--50 mU/kg), plasma clearance rate (PCR, dose/area of the incremental plasma insulin concentrations) decreased with increasing dose, varying from 32 to 14 ml-min-1-kg-1 at normoglycemia. After peripheral insulin infusion (5--30 mU/kg), PCR (mean value 15 ml-min-1-kg-1) showed no certain dose-dependence, but transfer rate constants and distribution volumes did. Despite a detectable reentry of insulin from one or more extravascular pools to the plasma pool, transfer rate constants or distribution volumes could not be accurately determined. The shortcomings of conventional noncompartmental and compartmental models did not appear to be due to the dose-dependence demonstrated. Instead, the limitations of these models were caused mainly by the difficulty of defining a proper base-line concentration and, in particular, by the imprecision of the experimental data, indicating that it will be difficult to find more appropriate models from data obtained with unlabeled insulin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 736117     DOI: 10.1152/ajpendo.1978.235.6.E577

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  The future of open- and closed-loop insulin delivery systems.

Authors:  Terry G Farmer; Thomas F Edgar; Nicholas A Peppas
Journal:  J Pharm Pharmacol       Date:  2008-01       Impact factor: 3.765

2.  On the estimation of absorption of subcutaneous injected insulin from plasma concentrations using mathematical models.

Authors:  C Cobelli; A Mari; E Duner; F Mollo; R Nosadini
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

3.  Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.

Authors:  H Hirayama; Y Kasuya; T Kobayashi; T Itoh; A Yagishita; T Katakura; K Isono
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

4.  Evaluation of alternative model structures of metabolic systems: two case studies on model identification and validation.

Authors:  C Cobelli; A Ruggeri
Journal:  Med Biol Eng Comput       Date:  1982-07       Impact factor: 2.602

Review 5.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

6.  Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

Authors:  P De Feo; G Perriello; M M Ventura; F Calcinaro; G Basta; C Lolli; C Cruciani; A Dell'Olio; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

7.  Loss of beta cell function as fasting glucose increases in the non-diabetic range.

Authors:  I F Godsland; J A R Jeffs; D G Johnston
Journal:  Diabetologia       Date:  2004-07-13       Impact factor: 10.122

8.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Pharmacodynamics of insulin following intravenous and enteral administrations of porcine-zinc insulin to rats.

Authors:  R J Schilling; A K Mitra
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.